Biochemistry, Genetics and Molecular Biology
Preclinical Study
100%
Purkinje Cell
100%
Ataxin 1
100%
Mouse Model
50%
RNA Interference
50%
Posttranslational Modification
50%
Genetic Disorder
50%
Glutamine
50%
RNA Splicing
50%
Polyglutamine Tract
50%
Gene Expression
50%
Genetic Transcription
50%
RNA Gene
50%
CAG Repeat
50%
Breathing
50%
Phosphotransferase
50%
Kinase
50%
Mutant Protein
50%
Messenger RNA
50%
Keyphrases
Spinocerebellar Ataxia
100%
Neurodegeneration
100%
Molecular Mechanism
100%
ATXN1
100%
Protein Level
50%
Phosphorylation
25%
Purkinje Cell
25%
Cognitive Deficits
12%
MicroRNA
12%
Cerebellum
12%
Highly Stable
12%
Kinase Inhibitor
12%
Brain Regions
12%
Post-translational Modification
12%
Aberrations
12%
Protein Loading
12%
Glutamine
12%
Cognitive Difficulties
12%
Adult-onset
12%
Gene Transcription
12%
Disease Onset
12%
Inherited Disease
12%
Mutant Protein
12%
Gene Expression Level
12%
Palliative Care
12%
RNA Splicing
12%
Polyglutamine Tract
12%
Normal Function
12%
Viral Delivery
12%
PiRNA Pathway
12%
Mouse Infection
12%
Control of Breathing
12%
Repeat mutation
12%
CAG Repeat
12%
Pharmacology, Toxicology and Pharmaceutical Science
Preclinical Study
100%
Spinocerebellar Degeneration
100%
Nerve Degeneration
100%
Diseases
100%
Ataxin 1
50%
Mouse Model
25%
Cognitive Defect
25%
Genetic Disorder
25%
microRNA
25%
Phosphotransferase Inhibitor
25%
Mutant Protein
25%
Polyglutamine
25%
Gene Delivery
25%
Glutamine
25%
Messenger RNA
25%
Neuroscience
Spinocerebellar Ataxia
100%
Neurodegeneration
100%
Purkinje Cell
50%
Ataxin 1
50%
Kinase
25%
MicroRNA
25%
Cognitive Disorders
25%
Glutamine
25%
Cerebellum
25%
Gene Expression
25%
Genetic Transcription
25%
CAG Repeat
25%
Mutant Protein
25%
Polyglutamine
25%
RNA Gene
25%
Posttranslational Modification
25%
RNA Splicing
25%
Messenger RNA
25%